CD79a antibody (AA 202-216)
Quick Overview for CD79a antibody (AA 202-216) (ABIN6294397)
Target
See all CD79a (CD79A) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 202-216
-
Purpose
- Rabbit anti-Human/Mouse/Rat/Monkey/Pig/Cow Recombinant CD79a Antibody [Sodium Azide Free]
-
Specificity
- Cell surface, cytoplasmic
-
Purification
- Amino acids 202-216 (GTYQDVGSLNIADVQ) were used as the immunogen for the recombinant CD79a antibody.
-
Immunogen
- Amino acids 202-216 (GTYQDVGSLNIADVQ) were used as the immunogen for the recombinant CD79a antibody.
-
-
-
-
Application Notes
-
Flow Cytometry: 0.5-1 μg/million cells in 0.1ml
Immunofluorescence: 0.5-1 μg/mL
IHC (FFPE): 0.25-0.5 μg/mL for 30 min at RT
Prediluted IHC only format: incubate for 30 min at RT (1) -
Restrictions
- For Research Use only
-
-
-
Buffer
- In 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.
-
-
- CD79a (CD79A) (B-cell antigen receptor complex-associated protein alpha chain (CD79A))
-
Alternative Name
- B-cell antigen receptor complex-associated protein alpha chain
-
Background
-
Target Description: A disulphide-linked heterodimer, consisting of mb-1 (or CD79a) and B29 (or CD79b) polypeptides, is non-covalently associated with membrane-bound immunoglobulins on B cells. This complex of mb-1 and B29 polypeptides and immunoglobulin constitute the B cell Ag receptor. CD79a first appears at pre B cell stage, early in maturation, and persists until the plasma cell stage where it is found as an intracellular component. CD79a is found in the majority of acute leukemias of precursor B cell type, in B cell lines, B cell lymphomas, and in some myelomas. It is not present in myeloid or T cell lines. Anti-CD79a is generally used to complement anti-CD20 especially for mature B-cell lymphomas after treatment with Rituximab (anti-CD20). This antibody will stain many of the same lymphomas as anti-CD20, but also is more likely to stain B-lymphoblastic lymphoma/leukemia than is anti-CD20. Anti-CD79a also stains more cases of plasma cell myeloma and occasionally some types of endothelial cells as well.
Gene Symbol: CD79A///IGA///MB1
-
Gene ID
- 973
-
UniProt
- P11912
-
Pathways
- BCR Signaling
Target
-